{
  "retracted": false,
  "timestamp": 1191283200000,
  "updates": [
    {
      "timestamp": 1550375692050,
      "identifier": {
        "doi": "10.1073/pnas.0708144104"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1073/pnas.0611693104"
  },
  "publisher": "Proceedings of the National Academy of Sciences",
  "title": "Correction for Scott et al., A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors"
}
